Hepatobiliary complications of cystic fibrosis (Q35765194)

10 August 2017

1 reference

title

Hepatobiliary complications of cystic fibrosis (English)

1 reference

10 August 2017

0 references

Andrew P Feranchak

1

1 reference

10 August 2017

1 June 2004

1 reference

Current gastroenterology reports

10 August 2017

1 reference

10 August 2017

6

1 reference

10 August 2017

3

1 reference

10 August 2017

231-239

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-004-0013-6

10 August 2017

0 references

cites work

GTP-binding proteins regulate high conductance anion channels in rat bile duct epithelial cells.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-004-0013-6

Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-004-0013-6

Adenosine nucleotides in bile

21 January 2018

1 reference

12 December 2020

Cystic Fibrosis Heterozygote Resistance to Cholera Toxin in the Cystic Fibrosis Mouse Model

1 reference

12 December 2020

Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis

1 reference

12 December 2020

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

1 reference

12 December 2020

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

1 reference

12 December 2020

Adenosine triphosphate release and purinergic regulation of cholangiocyte transport

1 reference

12 December 2020

Liver cirrhosis and portal hypertension in cystic fibrosis

1 reference

12 December 2020

Prediction of liver fibrosis according to serum collagen VI level in children with cystic fibrosis

1 reference

12 December 2020

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis

1 reference

12 December 2020

Ultrasound evaluation of liver disease in cystic fibrosis as part of an annual assessment clinic: a 9-year review

1 reference

12 December 2020

Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis.

1 reference

12 December 2020

Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors

1 reference

12 December 2020

Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population.

1 reference

12 December 2020

Is the hemochromatosis gene a modifier locus for cystic fibrosis?

1 reference

12 December 2020

Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts

1 reference

12 December 2020

Serum glutathione S-transferase B1 activity as an index of liver function in cystic fibrosis

1 reference

12 December 2020

The lipid products of phosphoinositide 3-kinase contribute to regulation of cholangiocyte ATP and chloride transport

1 reference

12 December 2020

Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience

1 reference

12 December 2020

High-molecular-mass ("biliary") isoenzyme of alkaline phosphatase and the diagnosis of liver dysfunction in cystic fibrosis

1 reference

12 December 2020

Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome

1 reference

12 December 2020

Liver transplantation for hepatic cirrhosis in cystic fibrosis

1 reference

12 December 2020

Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease.

1 reference

12 December 2020

Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor

1 reference

12 December 2020

Serum CA 19?9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests

1 reference

12 December 2020

Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis

1 reference

12 December 2020

Plasma markers of platelet activation in cystic fibrosis liver and lung disease

1 reference

12 December 2020

Endogenous ATP release regulates Cl- secretion in cultured human and rat biliary epithelial cells

1 reference

12 December 2020

Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience.

1 reference

12 December 2020

Analysis of risk factors for the development of liver disease associated with cystic fibrosis

1 reference

12 December 2020

Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group

1 reference

12 December 2020

Are serum type III procollagen and prolyl hydroxylase useful as noninvasive markers of liver disease in patients with cystic fibrosis?

1 reference

12 December 2020

Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up

1 reference

12 December 2020

An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis

1 reference

12 December 2020

Regulation of cell volume in a human biliary cell line: activation of K+ and Cl- currents

1 reference

12 December 2020

Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy

1 reference

12 December 2020

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

1 reference

12 December 2020

Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice

1 reference

12 December 2020

Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis

1 reference

12 December 2020

Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease

1 reference

12 December 2020

Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13.

1 reference

12 December 2020

Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells

1 reference

12 December 2020

The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis

1 reference

12 December 2020

Liver disease and common-bile-duct stenosis in cystic fibrosis

1 reference

12 December 2020

Regulation of membrane chloride currents in rat bile duct epithelial cells

1 reference

12 December 2020

Cholangiocyte biology and cystic fibrosis liver disease

1 reference

12 December 2020

Volume-sensitive purinergic signaling in human hepatocytes

1 reference

12 December 2020

Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee

1 reference

12 December 2020

Natural history of liver disease in cystic fibrosis

1 reference

12 December 2020

10.1007/S11894-004-0013-6

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15128491